SCHEMBL20899666

SCHEMBL20899666

NS(=O)(=O)c1ccccc1-c1ccsc1-c1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.48
CYP2E1 P05181 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2B6 P20813 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
PTGS2 P35354 4/20 0.41
NPC1 O15118 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
STAT3 P40763 1/20 0.39
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
PTGS1 P23219 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5488230 0.81 CA2 (0.56) CYP2A6CYP3A4CA2CA9CA12
SCHEMBL24318549 0.76 CYP2A6 (0.66) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL20899657 0.73 PTPRC (0.45) CYP2C9CA2CA9CA12CA1
SCHEMBL9130312 0.72 CA9 (0.46) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL28462214 0.72 STAT3 (0.52) CA2CA9CA12CA1PTGS2
SCHEMBL8629752 0.70 CA2 (0.43) CYP3A4CA2CA9CA12CA1
SCHEMBL1080972 0.69 CA2 (0.61) CYP2C9CA2CA9CA12CA1
SCHEMBL13733557 0.69 ALOX5AP (0.51) CYP2C9CA2CA9CA12CA1
SCHEMBL3248283 0.69 PTGS1 (0.63) PTGS2PTGS1
SCHEMBL8480076 0.68 PTGS2 (0.52) CYP3A4CA2CA9CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019075394-A1 COMPOUNDS FOR TREATMENT OF EMOTIONAL/PSYCHOLOGICAL SYMPTOMS IN FRAGILE X SYNDROME VANDERKLISH PETER (US) 2019-04-18 WO disclosed